203 related articles for article (PubMed ID: 18846421)
1. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract][Full Text] [Related]
2. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
4. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
5. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
6. [Mammaglobin mRNA measurement in the detection of micrometastasis in peripheral blood of breast cancer patients].
Liu N; Zhang W; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):317-9. PubMed ID: 11783116
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients.
Lin YC; Chen SC; Hsueh S; Lo YF; Chow-Wu YH; Liaw IC; Cheng AJ
Cancer Sci; 2003 Jan; 94(1):99-102. PubMed ID: 12708482
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients.
Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R
Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378
[TBL] [Abstract][Full Text] [Related]
9. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.
Zach O; Kasparu H; Krieger O; Hehenwarter W; Girschikofsky M; Lutz D
J Clin Oncol; 1999 Jul; 17(7):2015-9. PubMed ID: 10561252
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
12. [Detection of mammaglobin mRNA as a marker for circulating tumor cells in breast carcinoma].
Zach O; Kasparu H; Wagner H; Krieger O; Lutz D
Acta Med Austriaca Suppl; 2000; 52():13-5. PubMed ID: 11261271
[TBL] [Abstract][Full Text] [Related]
13. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.
Grünewald K; Haun M; Urbanek M; Fiegl M; Müller-Holzner E; Gunsilius E; Dünser M; Marth C; Gastl G
Lab Invest; 2000 Jul; 80(7):1071-7. PubMed ID: 10908152
[TBL] [Abstract][Full Text] [Related]
14. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.
Tjensvoll K; Oltedal S; Heikkilä R; Kvaløy JT; Gilje B; Reuben JM; Smaaland R; Nordgård O
BMC Cancer; 2012 May; 12():190. PubMed ID: 22640166
[TBL] [Abstract][Full Text] [Related]
15. Detection of mammaglobin expressing cells in blood of breast cancer patients.
Suchy B; Austrup F; Driesel G; Eder C; Kusiak I; Uciechowski P; Grill HJ; Giesing M
Cancer Lett; 2000 Oct; 158(2):171-8. PubMed ID: 10960767
[TBL] [Abstract][Full Text] [Related]
16. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
[TBL] [Abstract][Full Text] [Related]
17. [Expression of human mammaglobin mRNA in peripheral blood of breast cancer and their implication].
Li S; Li J; Luo C; Yu B; An P; Cai H
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):168-70. PubMed ID: 11955406
[TBL] [Abstract][Full Text] [Related]
18. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
19. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
20. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
